KDP vs STRO · P/E 23, rev $15.35B vs rev $62.0M
Keurig Dr Pepper Inc (KDP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported KDP revenue for 2024-12-31 was $15.35B. Net income was $1.44B. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the KDP and STRO stock pages for the full models.
Not investment advice.